Acadia Healthcare Q2 revenue beats in inpatient growth but costs bite
ACHC•Key quarterly figures
| Metric | Beat/Miss | Actual | Consensus Estimate |
|---|---|---|---|
| Q2 Revenue | Beat | $865.84 mln | $844.23 mln (10 Analysts) |
| Q2 Net Income | $12.26 mln | ||
| Q2 Adjusted EBITDA | Slight Beat* | $149.20 mln | $148.18 mln (11 Analysts) |
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Guidance raised for 2026
- Acadia Healthcare raises 2026 revenue guidance to $3.40-$3.45 bln from $3.37-$3.45 bln
- Company lifts 2026 adjusted EBITDA forecast to $590-$615 mln from $580-$615 mln
- Acadia Healthcare increases 2026 operating cash flow outlook to $350-$400 mln from $285-$325 mln
Q2 revenue beats on inpatient growth
- US behavioral healthcare provider's Q2 revenue was flat yr/yr, beating analyst expectations
- Adjusted EBITDA for Q2 slightly beat analyst consensus
- Company added 240 licensed beds from newly constructed facilities in Q2
Higher costs and payment timing weighed on results
- Supplemental payment timing - Flat revenue and same-facility revenue were impacted by the timing of supplemental payment program revenue in Florida and Tennessee
